Log in
NASDAQ:CMPS

COMPASS Pathways Stock Forecast, Price & News

$32.00
-1.13 (-3.41 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$30.55
Now: $32.00
$33.00
50-Day Range N/A
52-Week Range
$22.51
Now: $32.00
$47.29
Volume166,438 shs
Average Volume830,306 shs
Market Capitalization$1.11 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom.
Read More
COMPASS Pathways logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CMPS
CUSIPN/A
CIKN/A
Phone44 64 6905 3974
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$1.11 billion
Next Earnings DateN/A
OptionableNot Optionable
$32.00
-1.13 (-3.41 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CMPS News and Ratings via Email

Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











COMPASS Pathways (NASDAQ:CMPS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of COMPASS Pathways?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COMPASS Pathways in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for COMPASS Pathways
.

What price target have analysts set for CMPS?

5 Wall Street analysts have issued 12-month price targets for COMPASS Pathways' shares. Their forecasts range from $50.00 to $80.00. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next twelve months. This suggests a possible upside of 103.1% from the stock's current price.
View analysts' price targets for COMPASS Pathways
.

Who are some of COMPASS Pathways' key competitors?

What other stocks do shareholders of COMPASS Pathways own?

Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN).

When did COMPASS Pathways IPO?

(CMPS) raised $100 million in an initial public offering on Friday, September 18th 2020. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager.

What is COMPASS Pathways' stock symbol?

COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS."

When did COMPASS Pathways' quiet period expire?

COMPASS Pathways' quiet period expired on Wednesday, October 28th. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. The total size of the offering was $127,500,000 based on an initial share price of $17.00. During COMPASS Pathways' quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are COMPASS Pathways' major shareholders?

COMPASS Pathways' stock is owned by a number of retail and institutional investors. Top institutional investors include Kornitzer Capital Management Inc. KS (0.22%).

Which institutional investors are buying COMPASS Pathways stock?

CMPS stock was acquired by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS.

How do I buy shares of COMPASS Pathways?

Shares of CMPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is COMPASS Pathways' stock price today?

One share of CMPS stock can currently be purchased for approximately $32.00.

How big of a company is COMPASS Pathways?

COMPASS Pathways has a market capitalization of $1.11 billion.

What is COMPASS Pathways' official website?

The official website for COMPASS Pathways is www.compasspathways.com.

How can I contact COMPASS Pathways?

The company can be reached via phone at 44 64 6905 3974.

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.